Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
click here, the HCV drug pipeline click here, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
Editor-in-Chief
HCV Advocate
HBV Advocate

Wednesday, December 22, 2010

Cumberland Says FDA Rejects Liver Drug's New Indication

The drug, Acetadote, is currently approved to treat liver failure caused by an overdose of acetaminophen, a common ingredient in painkillers.

In March the company had filed a supplementary new drug application for an indication of the drug to treat liver failure caused by factors such as hepatitis B and autoimmune hepatitis.


Read more.........

No comments:

Post a Comment